Cell Care Therapeutics Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Cell Care Therapeutics is a biotechnology company focused on developing a new class of biologics derived from the secreted proteins and exosomes of mesenchymal stromal cells. Its approach centers on leveraging the signaling molecules produced by MSCs to support vascular health and surrounding tissue, with an early product aimed at treating diabetic macular edema, a leading cause of vision loss among working-age adults. Based in Monrovia, California, the company operates within the biotechnology research sector and targets conditions where vascular and tissue support can help mitigate inflammatory and degenerative processes. The organization is relatively small, reflecting its early-stage status as it advances its first product in pursuit of preclinical and translational development in ocular therapies. A recent development noted is the initiation of seed funding in 2018 to support its preclinical activities for ocular inflammatory diseases.